Ascendis Pharma A/S
Ascendis Pharma A/S is a Denmark-based company in the Healthcare sector with a market capitalisation of $14.9B. Its FinScore is 59/100; its highest-scoring layer is Quality (67) and its lowest is Growth (0). The shares trade at 17.5x trailing earnings and are up 6% year to date.
Share price performance
About Ascendis Pharma A/S
ascendispharma.comAscendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
- Sector
- Healthcare
- Industry
- Biotechnology
- HQ
- Denmark
- Fiscal year-end
- December
- Trading currency
- USD
- Reporting currency
- EUR
- Fundamentals updated
- 63 days ago
- Market cap
- $14.9B
- P/E (TTM)
- 17.5x
- Beta (issuer)
- 0.41
- Revenue (latest FY)
- €691.7M
Revenue breakdown
- North America65.4%€233.2M
- Europe34.6%€123.3M
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Ascendis Pharma A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Ascendis Pharma A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Ascendis Pharma A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Ascendis Pharma A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Ascendis Pharma A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Ascendis Pharma A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.